The Extracellular Matrix and the Cytoskeleton in Heart Hypertrophy and Failure

Cell characteristics and phenotype depend on the nature of the extracellular matrix, the type and organization of integrins and cytoskeleton. The interactions between these components are poorly known at the myocyte level and during cardiac remodeling associated with cardiac hypertrophy and heart failure. We analyze here the nature and organization of extracellular matrix (ECM) proteins, cytoskeleton and integrins and their regulation by growth factors, such as angiotensin II, in normal myocyte growth and in pathological growth (hypertrophy) of the myocardium and heart failure.

[1]  A. Gerdes,et al.  Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling. , 1999, Journal of molecular and cellular cardiology.

[2]  G. Taffet,et al.  The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. , 1999, Journal of molecular and cellular cardiology.

[3]  M. Hoshijima,et al.  Angiotensin II transduces its signal to focal adhesions via angiotensin II type 1 receptors in vascular smooth muscle cells , 1995, FEBS letters.

[4]  K. Weber,et al.  Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. , 1994, Journal of molecular and cellular cardiology.

[5]  John P. Geibel,et al.  Cyclic strain induces reorganization of integrin α5β1 and α2β1 in human umbilical vein endothelial cells , 1997 .

[6]  A. Friedl,et al.  Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. , 1991, Circulation.

[7]  Kenneth M. Yamada,et al.  Integrin transmembrane signaling and cytoskeletal control. , 1995, Current opinion in cell biology.

[8]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[9]  P. Sil,et al.  Angiotensin II and myocyte growth: role of fibroblasts. , 1997, Hypertension.

[10]  P. Jones,et al.  Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. , 2000, The Journal of clinical investigation.

[11]  K. Tryggvason,et al.  The laminin family. , 1993, Current opinion in cell biology.

[12]  Y. Yazaki,et al.  Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. , 1999, Circulation research.

[13]  J. Schaper,et al.  Extracellular matrix deposition in hypertensive hearts antifibrotic effects of ramipril. , 1995, European heart journal.

[14]  Sheila M. Thomas,et al.  Binding of paxillin to α4 integrins modifies integrin-dependent biological responses , 1999, Nature.

[15]  HiroakiMatsubara.  Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases , 1998 .

[16]  F. Giancotti,et al.  Complexity and specificity of integrin signalling , 2000, Nature Cell Biology.

[17]  A. Sabri,et al.  Fibronectin and basement membrane in cardiovascular organogenesis and disease pathogenesis. , 1996, Cardiovascular research.

[18]  Y. Toya,et al.  Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[19]  J. Schwarzbauer.  Fibronectin: from gene to protein. , 1991, Current opinion in cell biology.

[20]  C. Turner,et al.  Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. , 1995, Journal of cell science.

[21]  T. Ikemura,et al.  The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C , 1994, The Journal of cell biology.

[22]  E Ruoslahti,et al.  Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. , 1998, The Journal of clinical investigation.

[23]  T. Borg,et al.  Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix , 1994, Journal of cellular physiology.

[24]  G. Butler-Browne,et al.  Desmin Is Essential for the Tensile Strength and Integrity of Myofibrils but Not for Myogenic Commitment, Differentiation, and Fusion of Skeletal Muscle , 1997, The Journal of cell biology.

[25]  Lorell Bh.  Transition from hypertrophy to failure. , 1997 .

[26]  M. Prevost,et al.  A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.

[27]  B. Lowes,et al.  Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. , 1996, Circulation.

[28]  B. Sumpio,et al.  Cyclic strain induces reorganization of integrin alpha 5 beta 1 and alpha 2 beta 1 in human umbilical vein endothelial cells. , 1997, Journal of cellular biochemistry.

[29]  Hiroshi Sato,et al.  Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. , 1998, Circulation research.

[30]  L. Thornell,et al.  Null mutation in the desmin gene gives rise to a cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.

[31]  K. Weber,et al.  Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. , 1996, Cardiovascular research.

[32]  J. Bishop,et al.  Regulation of cardiovascular collagen deposition by mechanical forces. , 1998, Molecular medicine today.

[33]  B. Swynghedauw,et al.  Different distributions of microtubules, desmin filaments and isomyosins during the onset of cardiac hypertrophy in the rat. , 1984, European journal of cell biology.

[34]  T K Borg,et al.  Expression of collagen binding integrins during cardiac development and hypertrophy. , 1991, Circulation research.

[35]  M. Zile,et al.  Effects of chronic mitral regurgitation on diastolic function in isolated cardiocytes. , 1993, Circulation research.

[36]  M. Goumans,et al.  Knockout and knockin of the beta1 exon D define distinct roles for integrin splice variants in heart function and embryonic development. , 1998, Genes & development.

[37]  K. Baker,et al.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. , 1990, The American journal of physiology.

[38]  H. Schunkert,et al.  Regulation of extracellular matrix proteins in pressure‐overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition , 1998, Journal of hypertension.

[39]  Richard T. Lee,et al.  Induction of Tenascin-C in Cardiac Myocytes by Mechanical Deformation , 1999, The Journal of Biological Chemistry.

[40]  E. Schiffrin,et al.  Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. , 1997, Journal of cardiovascular pharmacology.

[41]  J. Schaper,et al.  The extracellular matrix in human myocardium: Part I: Collagens I, III, IV, and VI. , 1991, Cardioscience.

[42]  D. Mann,et al.  Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. , 1998, Circulation.

[43]  C. Delcayre,et al.  Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. , 1999, Hypertension.

[44]  N. Severs,et al.  Dystrophin is not a specific component of the cardiac costamere. , 1997, Circulation research.

[45]  R. Hynes,et al.  Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons , 1992, Cell.

[46]  B. Palmer,et al.  Microtubules modulate cardiomyocyte beta-adrenergic response in cardiac hypertrophy. , 1998, The American journal of physiology.

[47]  R L Juliano,et al.  Integrin signaling and cell growth control. , 1998, Current opinion in cell biology.

[48]  K. Yamada,et al.  Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors , 1996, The Journal of cell biology.

[49]  S. Sen,et al.  Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. , 1997, Cardiovascular research.

[50]  T. Kadowaki,et al.  Hypoxia induces activation and subcellular translocation of focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes. , 1999, Biochemical and biophysical research communications.

[51]  L. Silengo,et al.  Muscle β1D Integrin Reinforces the Cytoskeleton–Matrix Link: Modulation of Integrin Adhesive Function by Alternative Splicing , 1997, The Journal of cell biology.

[52]  George Cooper,et al.  Association of Tyrosine-phosphorylated c-Src with the Cytoskeleton of Hypertrophying Myocardium* , 1997, The Journal of Biological Chemistry.

[53]  Simon C Watkins,et al.  Microtubules and desmin filaments during onset of heart hypertrophy in rat: a double immunoelectron microscope study. , 1987, Circulation research.

[54]  R. Fässler,et al.  Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin. , 1996, Journal of cell science.

[55]  S. Reipert,et al.  Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. , 1999, Experimental cell research.

[56]  W. Hsueh,et al.  Integrins, adhesion, and cardiac remodeling. , 1998, Hypertension.

[57]  S. Shapiro,et al.  Matrix metalloproteinase degradation of extracellular matrix: biological consequences. , 1998, Current opinion in cell biology.

[58]  B. A. Harder,et al.  Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes , 1997, Journal of Molecular Medicine.

[59]  J. Leddy,et al.  The Association of Cardiac Dystrophin with Myofibrils/Z-disc Regions in Cardiac Muscle Suggests a Novel Role in the Contractile Apparatus (*) , 1996, The Journal of Biological Chemistry.

[60]  M. Eghbali,et al.  Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. , 1990, Circulation research.

[61]  J. Woessner,et al.  Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. , 1996, The American journal of pathology.

[62]  T. Borg,et al.  In vitro studies on adult cardiac myocytes: Attachment and biosynthesis of collagen type IV and laminin , 1988, Journal of cellular physiology.

[63]  G. Laurent,et al.  Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. , 1995, European journal of cell biology.

[64]  C. Pham,et al.  β1 Integrins Participate in the Hypertrophic Response of Rat Ventricular Myocytes , 1998 .

[65]  G. Dorn,et al.  The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. , 1996, Journal of molecular and cellular cardiology.

[66]  K. Campbell.  Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage , 1995, Cell.

[67]  T. Borg,et al.  Expression of collagen adhesion proteins and their association with the cytoskeleton in cardiac myocytes , 1989, The Anatomical record.

[68]  P. Watson,et al.  Desmin gene expression in cardiac myocytes is responsive to contractile activity and stretch. , 1996, The American journal of physiology.

[69]  T. Borg,et al.  Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes. , 1997, The American journal of physiology.

[70]  M. Zile,et al.  Role of microtubules in the contractile dysfunction of hypertrophied myocardium. , 1994, Journal of the American College of Cardiology.

[71]  B. Lorell.  Transition from hypertrophy to failure. , 1997, Circulation.

[72]  R. Chiquet‐Ehrismann.  Tenascins, a growing family of extracellular matrix proteins , 1995, Experientia.

[73]  D. Menick,et al.  Cardiac Hypertrophic and Developmental Regulation of the β-Tubulin Multigene Family* , 1999, The Journal of Biological Chemistry.

[74]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[75]  V. Ferrans.  Human cardiac hypertrophy: structural aspects. , 1982, European heart journal.

[76]  C. Chassagne,et al.  Expression of laminin α2 chain during normal and pathological growth of myocardium in rat and human , 2000 .

[77]  J. S. Janicki,et al.  Remodeling of the rat right and left ventricles in experimental hypertension. , 1990, Circulation research.

[78]  A. Corbier,et al.  Fibronectin expression during physiological and pathological cardiac growth. , 1995, Journal of molecular and cellular cardiology.

[79]  L. Silengo,et al.  Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development. , 1998, Cell adhesion and communication.

[80]  A. Chobanian,et al.  Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. , 1994, Circulation research.

[81]  M. Rabinovitch,et al.  Nitric oxide mediates LC‐3‐dependent regulation of fibronectin in ductus arteriosus intimal cushion formation , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  J. Thyberg,et al.  Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.

[83]  H. E. Keurs.  Microtubules in Cardiac Hypertrophy: A Mechanical Role in Decompensation? , 1998 .

[84]  J. Samuel,et al.  Microtubules in cardiac myocytes. , 1988, International review of cytology.

[85]  P. Brecher,et al.  Fibronectin expression in the normal and hypertrophic rat heart. , 1992, The Journal of clinical investigation.

[86]  V. Koteliansky,et al.  Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[87]  S. Tyagi.  Extracellular matrix dynamics in heart failure: A prospect for gene therapy , 1998, Journal of cellular biochemistry.

[88]  Price Mg,et al.  Intermediate filaments in striated muscle. A review of structural studies in embryonic and adult skeletal and cardiac muscle. , 1983 .

[89]  Y. Capetanaki,et al.  Disruption of muscle architecture and myocardial degeneration in mice lacking desmin , 1996, The Journal of cell biology.

[90]  H. Lassmann,et al.  Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. , 1997, Genes & development.

[91]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[92]  J. Thiery,et al.  Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. , 1991, The Journal of clinical investigation.

[93]  P. Poitevin,et al.  Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[94]  S. Meloche,et al.  Angiotensin II Stimulates Tyrosine Phosphorylation of the Focal Adhesion-associated Protein Paxillin in Aortic Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[95]  F. Villarreal,et al.  Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. , 1992, The American journal of physiology.

[96]  P. Jones,et al.  Regulation of Tenascin-C, a Vascular Smooth Muscle Cell Survival Factor that Interacts with the αvβ3 Integrin to Promote Epidermal Growth Factor Receptor Phosphorylation and Growth , 1997, The Journal of cell biology.

[97]  Robert,et al.  Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[98]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[99]  G. Vassort,et al.  Microtubule disruption modulates Ca(2+) signaling in rat cardiac myocytes. , 2000, Circulation research.

[100]  V. Koteliansky,et al.  Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells , 1996, The Journal of cell biology.

[101]  Y. Sun,et al.  Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. , 1998, Circulation.

[102]  C. Delcayre,et al.  Biological determinants of aldosterone-induced cardiac fibrosis in rats. , 1995, Hypertension.

[103]  E. Adamson,et al.  Vinculin knockout results in heart and brain defects during embryonic development. , 1998, Development.

[104]  K. Chien,et al.  Stress Pathways and Heart Failure , 1999, Cell.

[105]  J. W. Sanger,et al.  Intermediate filaments in striated muscle. A review of structural studies in embryonic and adult skeletal and cardiac muscle. , 1983, Cell and muscle motility.

[106]  Hisahiro Yu,et al.  Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. , 1997, Hypertension.

[107]  Hiroshi Sato,et al.  Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy , 1997, Journal of Cell Biology.

[108]  I. Zachary,et al.  Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[109]  Jean-SébastienSilvestre,et al.  Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction , 1999 .

[110]  F. Spinale,et al.  Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy. , 1995, The American journal of physiology.

[111]  Y. Mori,et al.  Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. , 1997, Circulation.